Seasonal Allergy

Food Allergy

Anaphylaxis

Allergy

Biosimilars

Dyslipidemia

Arrhythmia

Structural Heart Disease

Atherosclerotic Cardiovascular Disease

Heart Failure

Lipid Management

Hypertension

Stroke

Venous Thromboembolism

Cardiology

Vitiligo

Acne

Atopic Dermatitis

Chronic Idiopathic Urticaria

Plaque Psoriasis

Rosacea

Dermatology

Type 2 Diabetes

Type 1 Diabetes

Polycystic Ovary Syndrome

Hormonal Disorders

Thyroid Disorders

Endocrinology

FDA News

COVID-19

Influenza

Vaccination

Family Medicine

C Difficile Infection

Gastroesophageal Reflux Disease (GERD)

Hepatitis C

Irritable Bowel Syndrome

Peptic Ulcer

Ulcerative Colitis

Gastroenterology

Alzheimer Disease

Parkinson Disease

Geriatrics

Hepatology

Hospital Medicine

HIV/AIDS

Infectious Disease

Internal Medicine

Chronic Kidney Disease

Nephrology

Epilepsy

Migraine

Tardive Dyskinesia

Traumatic Brain Injury

Neurology

Obesity Management

Geographic Atrophy

Age-Related Macular Degeneration

Diabetic Macular Edema

Uveitis

Ophthalmology

Acute Pain

Chronic Pain

Multiple Sclerosis

Neuropathic Pain

Pain

Pediatrics

PTSD

Addiction

ADHD

Bipolar Disorder

Major Depressive Disorder

Schizophrenia

Psychiatry

Lung Cancer

Pulmonary Fibrosis

Asthma

COPD

Pulmonology

Vasculitis

Sickle Cell

Amyloidosis

Huntington Disease

Lysosomal Storage Disorders

Rare Disease Report®

Lupus

Osteoporosis

Non-radiographic Axial Spondyloarthritis

Ankylosing Spondylitis

Fibromyalgia

Gout

Osteoarthritis

Psoriatic Arthritis

Rheumatoid Arthritis

Spondyloarthritis

Rheumatology

Obstructive Sleep Apnea

Insomnia

Sleep

Plastic surgery

Surgery

Women's Health

News

Media

Medical World News

Podcasts

Shows

State Of Sciences - Presentations

Videos

Webinars

Multimedia Series

CURE Connections®

Insights

Medcast Podcasts

Medcast Videos

Peer Exchange

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

Partners

CME/CE

Resources

Interactive Tools

Live Events

Press Release

Publications

Subscribe

Articles

New prospective data show more adult patients achieved clinical response with ketamine than the historic standard ECT over a 6-month regimen.

Ketamine Noninferior to Electroconvulsive Therapy for Treatment-Resistant Depression

. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with 

. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

There were several risk factors identified, including abortion, hospitalization, past surgical procedure,  dental extraction, delivery in hospital, injection in hospitals, and household contact with jaundice.

Investigators Identify Risk Factors for HBV, HCV Among Pregnant Women

Patrick Campbell is the managing editor of HCPLive. Formerly the editorial lead of Endocrinology Network, Practical Cardiology, and Rheumatology Network, Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. He now helps to lead coverage in each of these respective areas for HCPLive. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.

Ahead of the sotagliflozin approval, Deepak Bhatt, MD, MPH, offers perspective into potential future research opportunities for the SGLT1/2 inhibitor and discusses the impact of a 3rd agent boasting SGLT2 inhibition receiving approval for heart failure.

Exploring the Impact of the Sotagliflozin Approval, with Deepak Bhatt, MD, MPH

Tim Smith joined the MJH Life Sciences team as an assistant editor for HCPLive in August 2022. He graduated from UC Berkeley with a degree in political science, working in multimedia journalism as a staff writer prior to joining MJH. In his spare time, he enjoys reading, watching TV, listening to podcasts, and rock climbing. You can contact him at 

New research has led to the development of an algorithm designed to help improve detection of allergic reactions to antibiotics, given that antibiotics are among the most common medication adverse event causes.


Electronic Tool Developed to Help Clinicians Detect Antibiotic Allergic-Type Reactions

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

About Us

Advertise

Editorial

Contact Us

Do Not Sell My Information

Privacy

Terms & Conditions

HCPLive - Clinical news for connected physicians

Facebook

Twitter

LinkedIn

Spotlight

Biosimilars Spotlight

Qazi Corner

This Year In Medicine 2022

Clinical

Arterial Disease

Diabetes

Geriatric Medicine

Video Series

News Network

Post Conference Perspectives

View

Experts discuss several topics pertaining to dry eye disease, including challenges and unmet needs, current and emerging treatment options, and tailoring treatment strategies based on individual patient factors.

Ophthalmologist experts provide an overview of dry eye disease. 

Dry Eye Disease Overview

Laura Periman, MD, discusses the prevalence and risk factors of dry eye disease. 

Prevalence and Risk Factors of Dry Eye Disease

Brandon Ayres, MD, discusses the pathophysiology of dry eye disease related to obstruction and inflammation. 

Pathophysiology of Dry Eye Disease

Eric Donnenfeld, MD, discusses initiating treatment for dry eye disease.

Initiating Dry Eye Treatment

Experts provide an overview of the diagnostic process for identifying dry eye disease.

Dry Eye Disease Diagnosis

Experts discuss diagnosing meibomian gland dysfunction (MGD), the most common cause of dry eye disease.

MGD Diagnosis

Kendall Donaldson, MD, MS, and I. Paul Singh, MD, describe the first-line approach to treating dry eye disease. 

Treatment Approaches to Dry Eye Disease

Eric Donnenfeld, MD, provides an overview of different anti-inflammatory agents treatment options for dry eye disease.

Anti-inflammatory Agents in Dry Eye Disease

Laura Periman, MD, describes the mechanism of action of lifitegrast for the treatment of dry eye disease.

Lifitegrast Mechanism of Action

Brandon Ayres, MD, provides an overview of lifitegrast efficacy and safety from the OPUS trials for the treatment of dry eye disease.

Lifitegrast Efficacy and Safety in Phase 3 Trials

Experts discuss data from the OPUS trials for the treatment of dry eye disease. 

Dry Eye Disease: OPUS Trials

Ophthalmologist experts discuss the rationale for choosing specific treatments for dry eye disease.

Choosing a Treatment for Dry Eye Disease

Laura Periman, MD, describes different procedural therapies for the treatment of dry eye disease.

Procedural Therapies for Dry Eye Disease

Experts discuss managing patients with overlapping eye diseases that require concurrent treatment, including before cataract and refractive surgery. 

Managing Dry Eye Disease Before Cataract and Refractive Surgery

Ophthalmologist experts discuss treating patients with dry eye disease who wear contacts. 

Dry Eye Disease: Patients With Contacts

Ophthalmologist experts provide an overview of emerging treatments for dry eye disease. 

Emerging Treatments for Dry Eye Disease

Advances in the Management and Treatment of Dry Eye Disease

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Dry Eye Disease: Patients With Contacts

EP: 1.Dry Eye Disease Overview

EP: 2.Prevalence and Risk Factors of Dry Eye Disease

EP: 3.Pathophysiology of Dry Eye Disease

EP: 4.Initiating Dry Eye Treatment

EP: 5.Dry Eye Disease Diagnosis

EP: 6.MGD Diagnosis

EP: 7.Treatment Approaches to Dry Eye Disease

EP: 8.Anti-inflammatory Agents in Dry Eye Disease

EP: 9.Lifitegrast Mechanism of Action

EP: 10.Lifitegrast Efficacy and Safety in Phase 3 Trials

EP: 11.Dry Eye Disease: OPUS Trials

EP: 12.Choosing a Treatment for Dry Eye Disease

EP: 13.Procedural Therapies for Dry Eye Disease

EP: 14.Managing Dry Eye Disease Before Cataract and Refractive Surgery

EP: 15.Dry Eye Disease: Patients With Contacts

EP: 16.Emerging Treatments for Dry Eye Disease